All News
Las Vegas site joins global study on Alzheimer’s blood test
by News 3 Staff,Updated Fri, January 23, 2026 at 1:20 PM LAS VEGAS (KSNV) — Clinical Neurology Specialists (CNS) in Las Vegas is participating in a groundbreaking international study sponsored by the Global Alzheimer’s Platform Foundation. The Bio-Hermes-002 study seeks volunteers with memory concerns to help identify blood or digital tests that could predict the presence of amyloid […]
GenomeWeb: LifeArc Joins Study to Evaluate Alzheimer’s Disease Finger-Prick Blood Test
Jan 20, 2026 | staff reporterSave for later NEW YORK — UK nonprofit research organization LifeArc said on Monday that it has partnered with the Global Alzheimer’s Platform Foundation (GAP) to evaluate a blood-based test for Alzheimer’s disease. The test is designed to detect three proteins — phosphorylated tau 217, glial fibrillary acidic protein, and neurofilament light […]
Global Alzheimer’s Platform Foundation Applauds Congressional Funding Increase for Alzheimer’s Research
Washington D.C., Jan 20, 2026, The Global Alzheimer’s Platform Foundation® (GAP) applauds the House and Senate Committees on appropriations releasing their final bipartisan FY2026 Labor–Health and Human Services–Education appropriations bill which increases funding for Alzheimer’s disease and other dementia research. “Congress’s bipartisan approval of increased funding for neurodegenerative research sends a powerful message to the millions of […]
The Independent: The finger prick blood test that could revolutionise Alzheimer’s diagnosis
The test aims to pick up three proteins known to be associated with Alzheimer’s Jane KirbyMonday 19 January 2026 11:14 GMT Bookmark popover Removed from bookmarksClose popover A pioneering trial has begun to assess whether a simple finger-prick blood test could offer an early diagnosis for Alzheimer’s disease, even before symptoms manifest. Experts are optimistic […]
LifeArc: Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer’s disease before symptoms begin
A major international research project is underway to test whether a finger prick-style blood test could be used to help diagnose Alzheimer’s disease. The trial is looking at three proteins in the blood that are associated with Alzheimer’s and comparing this with the current gold standard approach to diagnosing the disease that uses expensive brain […]
Providence Business News: Providence research company seeking participants for Alzheimer’s study
By Jacquelyn Voghel 01/18/2026 EAST PROVIDENCE – A national research institution’s Rhode Island location is calling for volunteers with Alzheimer’s disease to participate in a study attempting to identify predictive markers of the brain condition. K2 Medical Research – East Providence has begun enrolling participants in the Bio-Hermes 002 Study, an initiative of the Global Alzheimer’s Platform Foundation. The study seeks […]
K2 Medical Research Providence Seeking Participants for Observational Study
K2 Now Enrolling in Innovative Study of Alzheimer’s Blood and Digital Biomarker Tests; Research Volunteers Receive No-Cost Brain Scan and Learn About Their Brain Health East Providence, RI- Jan 12, 2026 – – K2 Medical Research in Rhode Island has started enrolling volunteers with memory concerns in the Global Alzheimer’s Platform Foundation® (GAP)’s innovative Bio-Hermes-002 Study to […]
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Spear Bio for the Transformative Bio-Hermes-002 Study
Spear Bio joins collaborative study focused on new biomarkers designed to improvediagnosis of Alzheimer’s disease and dementias Washington D.C., Jan 12, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study. This collaboration will enhance this unique, observational platform […]
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Alamar Biosciences for the Transformative Bio-Hermes Studies
Washington D.C., Jan 9, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, to the Bio-Hermes studies. This collaboration will enhance the unique, observational platform studies that compare blood-based and digital biomarkers across a broad range of clinical […]
Clinical Neurology Specialists Partnering with Leading International Nonprofit to Accelerate Alzheimer’s Research in Las Vegas
Collaboration to Improve Access to Study for Alzheimer’s Disease Las Vegas, Nev. – Dec. 23 2025 – Today, Global Alzheimer’s Platform Foundation® (GAP) and Clinical Neurology Specialists (CNS) announced their collaboration to accelerate Alzheimer’s disease research in Las Vegas. CNS has joined the GAP-sponsored study, Bio-Hermes-002, a unique, observational platform study that compares blood-based and digital biomarkers […]